LifeScience
Thermo Fisher Scientific, the world leader in serving science, has opened a new sterile drug facility in Singapore that will better enable customers to del...
May 19, 2023 | News
GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has expanded its primary manufacturing facility fo...
May 19, 2023 | News
With this qualification, Discovery gains access to Akoya's PhenoImager® HT workflows, which can provide insights into the tumor microenvironment (...
May 19, 2023 | News
Boan Biotech announced today that its BA1202, a CEACAM5 (CEA)/CD3 bispecific antibody, has been approved for a clinical trial by the Center for Drug Evalua...
May 17, 2023 | News
With +80 US/EU peer reviewed publications, the oCelloScope is a one-of-a-kind workhorse in many microbial applications. In AST,...
May 17, 2023 | News
Discover how the combined technical expertise, talent, and portfolio offerings of these two distinguished brands are driving the next generation of medicin...
May 12, 2023 | News
ATTR-CM is caused by unstable transthyretin proteins that misfold and aggregate into amyloid fibrils that build up in the heart and other parts of the body...
May 12, 2023 | Analysis
Thermo Fisher Scientific, the world leader in serving science, today announced it is making ImmunoCAP™ Specific IgE tests available to more patients ...
May 11, 2023 | News
New distribution center officially opened in Enfield, Connecticut Targeted strengthening of the supply chain and of the customer focus throughout the Am...
May 11, 2023 | News
-Boehringer Ingelheim announced that it has launched clinical development of its first-in-class IL-11 inhibitor antibody BI 765423 with a Phase 1 stu...
May 11, 2023 | News
Increasing localized access can provide faster results for patients while potentially improving patient outcomes Agreement aims to enable greater access t...
May 10, 2023 | News
Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Tru...
May 09, 2023 | News
HMBD-011 is a potentially first-in-class anti-VH4-34 antibody developed for treatment of VH4-34+ antibody-driven pathogenesis in lupus and cold agglutini...
May 09, 2023 | News
The agreement focuses on activators of KCNQ2, an ion channel that has been clinically validated as a target for the treatment of epilepsy. Clinical findin...
May 09, 2023 | Opinion
Most Read
Bio Jobs
News
Editor Picks